First CAR to pass the road test: Tisagenlecleucel's drive to FDA approval Journal Article
| Author: | Geyer, M. B. |
| Article Title: | First CAR to pass the road test: Tisagenlecleucel's drive to FDA approval |
| Abstract: | In August 2017, the FDA took historic action in granting the first approval of gene therapy to tisagenlecleucel. This landmark step brought CAR T-cell therapy to the commercial space and heralded a new era in managing refractory B-cell malignancies and FDA oversight of gene-modified therapies. © 2018 American Association for Cancer Research. |
| Journal Title: | Clinical Cancer Research |
| Volume: | 25 |
| Issue: | 4 |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-02-15 |
| Start Page: | 1133 |
| End Page: | 1135 |
| Language: | English |
| DOI: | 10.1158/1078-0432.Ccr-18-3328 |
| PUBMED: | 30463849 |
| PROVIDER: | scopus |
| PMCID: | PMC6377838 |
| DOI/URL: | |
| Notes: | Source: Scopus |
